Wang, Jianping
Liu, Side
Wang, Hui
Zheng, Lei
Zhou, Changchun
Li, Guoxin
Huang, Rongkang
Wang, Huaiming
Li, Chujun
Fan, Xinjuan
Fu, Xinhui
Wang, Xinying
Guo, Hongliang
Guan, Jie
Sun, Yanlai
Song, Xilin
Li, Zengjun
Mu, Dianbin
Sun, Jujie
Liu, Xianglin
Qi, Yan
Niu, Feng
Chen, Chunhua
Wu, Xiaolin
Wang, Xianshu
Song, Xianrang
Zou, Hongzhi http://orcid.org/0000-0002-4870-6913
Funding for this research was provided by:
National Key Research and Development Program of China (2017YFC1308800)
National Key Clinical Specialty Discipline Construction Program of China
Creative Biosciences
Article History
Received: 3 June 2020
Accepted: 20 October 2020
First Online: 30 October 2020
Ethics approval and consent to participate
: The study was approved by the Institutional Review Board (IRB) at each of the three hospitals, The Sixth Affiliated Hospital of Sun Yat-sen University (IRB No.: C2017001), Nanfang Hospital of Southern Medical University (IRB No.: NFEC-201705-Q1), and Shandong Cancer Hospital and Institute (IRB No.: SDZLEC2017-021).
: All authors have their consent for publication.
: Xianglin Liu, Yan Qi, Feng Niu, Chunhua Chen, Xiaolin Wu, Xianshu Wang, and Hongzhi Zou are current employees from Creative Biosciences (Guangzhou) CO., Ltd. No potential conflicts of interests were disclosed by the other authors.